PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
San Francisco, June 10, 2025 (GLOBE NEWSWIRE) --
PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program, enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians. This development marks a critical milestone in the company's mission to provide affordable, clinically supervised weight management across the United States.
Accessible at https://plushcare.com/weight-loss/, the updated platform streamlines the process for eligible adults to consult with licensed physicians, receive lab work if necessary, and access customized treatment plans—all from the comfort of their homes.
'We're committed to making evidence-based weight loss solutions more accessible through modern telehealth,' said a PlushCare spokesperson. 'Our program is designed to connect people with experienced doctors who can evaluate eligibility for medications like GLP-1s and deliver a personalized plan that fits their health goals.'
Expanded Features for 2025
The revamped Weight Loss Program now includes:
Nationwide Access to medical providers via secure telehealth appointments
Eligibility Evaluation for FDA-approved medications, including semaglutide
Personalized Plans tailored to each user's metabolic profile
Optional Lab Testing with integrated results for precision treatment
Transparent Pricing with no insurance required
The platform is optimized for mobile and desktop users, offering a seamless experience from appointment scheduling to prescription delivery.
Addressing a Growing National Health Concern
According to the CDC, over 40% of U.S. adults struggle with obesity, with rising demand for effective clinical support. PlushCare's integrated virtual care model delivers a scalable solution that removes traditional geographic and scheduling barriers.
Patients can typically get started in under 15 minutes by completing an intake form and booking a same-day appointment with a licensed doctor. If clinically appropriate, a prescription is sent to their preferred pharmacy.
About PlushCare
PlushCare is a virtual primary care and mental health platform that connects patients with top U.S. medical professionals through its secure telehealth platform. With a commitment to quality care, convenience, and evidence-based treatment, PlushCare is redefining access to modern healthcare.
For more information, visit https://plushcare.com.
Media Contact:PlushCare Media RelationsEmail: press@plushcare.comWebsite: https://plushcare.comAddress: 345 California Street, Suite 600, San Francisco, CA 94105, United States
SOURCE: PlushCare
Disclaimer: This release contains forward-looking statements and should not be considered medical advice. All treatments are subject to clinical evaluation and provider discretion.
CONTACT: Email: press@plushcare.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
26 minutes ago
- Bloomberg
Roche May Sell Drugs Directly to US Patients to Bypass Middlemen
Roche Holding AG is weighing direct-to-patient drug sales in the US, bypassing the middleman for its pricey medicines for multiple sclerosis, eye disease and cancer. The Swiss drugmaker has discussed direct-to-patient sales with the US government, Chief Executive Officer Thomas Schinecker said on Thursday as the company reported quarterly earnings. The move would bring down costs 'quite quickly,' he said.
Yahoo
27 minutes ago
- Yahoo
Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close totalling over A$439m
MELBOURNE, Australia, July 24, 2025 (GLOBE NEWSWIRE) -- Brandon Capital, Australasia's leading life sciences venture capital firm, today announced the final close of its sixth fund at A$439 million. Joining existing investors Hesta, Host Plus, CSL and QIC are the WA Government and Australia's sovereign investor in manufacturing capability, the National Reconstruction Fund Corporation (NRFC). This final close of Brandon BioCatalyst Fund Six (BB6) will see Brandon Capital continue to invest in emerging biomedical technologies with strong commercial potential, translating these exciting discoveries into high-growth firms that positively impact human health. To date, Brandon Capital has raised over A$1 billion across previous funds with notable Fund Six investments to date including AdvanCell (radiopharma), PolyActiva (glaucoma implant), Myricx Bio (ADC) and CatalYm (oncology). Dr Chris Nave, Co-Founder and Managing Partner at Brandon Capital, 'We're excited to welcome the National Reconstruction Fund Corporation to our sixth fund, joining HESTA, Hostplus, CSL, QIC and the WA Government. Closing at $439 million, BB6 is our largest fund to date, and we remain committed to advancing breakthrough biomedical innovations through our unwavering scientific rigour and disciplined capital allocation, in pursuit of exceeding our investors' expectations.' The firm has a track record of advancing its portfolio companies to commercialisation. Recent Brandon Capital portfolio company announcements include FDA approvals for a hypertension therapy from George Medicines and a left ventricular cardiac resynchronisation device developed by EBR Systems, with Q-Sera's blood collection tubes that produce high-quality serum faster and more reliably, recently approved in Japan. Brandon Capital has an active portfolio of over 30 companies with 17 in clinical trials, four advancing or in-market, a promising preclinical pipeline and several actively contributing to Australia's high-skilled manufacturing sector growth. Collectively supporting over 270 high-skilled Australian jobs are: surgical imaging innovator, OncoRes Medical, which has developed the first 'real-time' in cavity probe to improve cancer surgery outcomes; late-stage biotech PolyActiva, which is developing a long-term treatment for glaucoma, the second leading cause of blindness; needle-free patch for vaccine delivery Vaxxas, and radiopharmaceutical company AdvanCell, which is developing novel therapies for the treatment of a range of cancers. NRFC CEO David Gall said, "Medical science has long development timelines, and it is important for the NRFC to make early and considered investments in the sector to attract the talent and capital that we will need to build our local commercialisation capabilities. If we want medical science jobs and industries to exist in Australia in ten years, we need to invest in them today." Brandon Capital, headquartered in Australia with offices in the UK and US, has established a transcontinental presence that strengthens collaboration across regions. Australian portfolio companies gain access to UK/EU/US capital, expertise, and pharma networks, while international companies benefit from Australia's world-class clinical trial and research capabilities. About Brandon Capital – Brandon Capital is Australasia's leading life sciences venture capital firm, with offices in Australia, New Zealand, the US and the UK. Its unique model includes proprietary deal flow through Brandon BioCatalyst, a collaboration of over 50 of ANZ's leading medical research institutions, and its immersive corporate services structure enables portfolio companies to focus on research commercialisation. With more than 30 active companies in its portfolio, Brandon Capital has been sourcing and supporting the transition of world-leading science into world-leading businesses for nearly two decades. For further information please contact Media – AustraliaKirrily Davis, E: kdavis@ M: +61 (0)401 220228 Media - InternationalSue Charles, Charles Consultants E: M: +44 (0)7968 726585 Chris Gardner, E: Chris@ M: +44 (0)7956 031077 About the National Reconstruction Fund Corporation (NRFC) The NRFC invests to diversify and transform Australia's industry and economy. It has $15 billion to invest using direct loans, equity investments and loan guarantees. The NRFC investment mandate covers seven priority areas including value-add in resources; transport; medical science; defence capability; renewables and low emission technologies; value-add in agriculture, forestry and fisheries; and enabling capabilities. The NRFC's role is to invest in Australian businesses and projects that design, refine and make in order to transform capability, grow jobs and a skilled workforce, and diversify our economy. NRFC is a corporate Commonwealth entity, established by the National Reconstruction Fund Corporation Act 2023 (NRFC Act) in September 2023. For more information, visit
Yahoo
37 minutes ago
- Yahoo
Nurse, 26, Lost 270 Pounds After Making These 3 Lifestyle Changes
When his doctor prescribed the first blood pressure medication, Kevin Goode knew his weight probably contributed to it. He was 465 pounds, but he thought his high blood pressure wasn't 'too serious.' Still, it remained high, and his doctor prescribed him a second drug to try to lower it. Soon after, he learned he had sleep apnea and his A1C was 'shooting upward.' If it didn't lower, Goode would need to add insulin to his growing list of prescriptions. Then his doctor gave him a warning. 'My doctor told me that I wouldn't live past 40 with this trend,' Goode, 28, a nurse at Riley Hospital for Children in Indianapolis, tells 'That's the moment that everything changed.' At the time, he was 26 and visited a bariatric surgeon for a consultation. The doctor advised Goode that he needed to lose weight before he qualified for surgery. He immediately headed to the gym and sat on a bench to lift some dumbbells. Soon, he started eating a moderate-fat, low-carbohydrate and high-protein diet. '(The doctor) wanted me to lose 20 pounds because that would show that I was dedicated enough for surgery,' Goode explains. 'I ended up losing 80 pounds.' In December 2023, he underwent surgery. As he recovered for six weeks, he was anxious to get back to his exercise routine. 'I was very much like, 'How soon can I get back to the gym?'' he says. 'I was sitting around doing nothing, and I'm not liking it.' Six weeks later, he was cleared to return to his regular exercise routine. Over time, he shed more weight, reaching 176 pounds. 'My goal from the beginning of this whole journey back in February of 2023 was, bluntly, to win back my life. It was never about the weight, never about the bodybuilding, never about looking good,' he says. 'It was very much about (how) I was told that I wouldn't live past 40, and that didn't sit right with me, and I wanted to get rid of all the diagnoses.' This year, Goode took his love of weight training to the next level and is working toward becoming a certified personal trainer. One of the trainers in the gym approached Goode and suggested he consider participating in a bodybuilding competition. 'He was like 'Have you ever thought about doing a show?' and I was like, 'No, I just love it here and I come for the health aspect,'' Goode recalls. 'That's when I looked into the transformation competition.' A transformation competition generally focuses on people who have lost weight. Goode will compete in October in Chicago. As part of his preparation, he has focused more on lifting and less on cardiovascular exercise. 'Instead of doing 45 minutes of strength training and 30 of cardio, it's more like an hour strength training and maybe 15 minutes cardio,' he says. This caused him to gain some weight, and he's now at 210 pounds, but it's 'more muscle.' His diet has changed, too, and he focuses on counting macronutrients. He still eats a lot of protein, but with lower-fat foods and now incorporates complex carbohydrates into his diet. Losing fat while gaining muscle has changed his outlook on calories and how important they are for energy, he says. Since losing weight and transforming his body with lifting, Goode feels he's become 'more emotionally intelligent.' 'I share a lot more about myself,' he says. 'I'm 20 times more confident than I have ever been in my life.' Ahead, Goode shares what worked for him when it came to transforming his body. 'Nutrition Is Going To Be Your Biggest Thing' Eating fewer calories than he burned, what's known as a calorie deficit, helped Goode shed the weight. 'Nutrition is going to be your biggest thing,' he says. 'The biggest advice as far as actually losing weight is just (being in) a calorie deficit.' 'Fall in Love with the Small Wins' Focusing too much on the scale can feel overwhelming. People might think they look great, but the scale shows their weight increased slightly. Instead of focusing on the numbers, Goode urges people to 'fall in love with the small wins.' Goode keeps a running list of his in his notes app. 'I don't have to pick up my foot to tie my shoe. I can just bend over,' he says. 'I always made a joke that laptops are not laptops. There's no way that is sitting on my lap. But now I'm like I got all this room.' But his 'biggest non-scale victory' has been the difference he's noticed at work. 'Being able to move around (the hospital) room a lot easier, being able to play with the kids without getting out of breath,' he says. 'I enjoy it so much more now because I'm not getting (to) the end of the 12-hour shifts completely, like, dead.' Find Support While Goode taught himself how to work out, he hasn't been entirely alone in his process. 'I had the community support from the gym. My mom has been a huge supporter. All the nurses at work, they've been fantastic,' he says. 'I can't go without mentioning my amazing girlfriend. She's just been super supportive.' This article was originally published on
